IL113073A - Pharmaceutical hypocholesterolemic and hypotriglyceridemic mercaptoacetylamide compositions containing disulfide derivatives of n-(tricyclic benzazepinyl) acetamide - Google Patents

Pharmaceutical hypocholesterolemic and hypotriglyceridemic mercaptoacetylamide compositions containing disulfide derivatives of n-(tricyclic benzazepinyl) acetamide

Info

Publication number
IL113073A
IL113073A IL11307395A IL11307395A IL113073A IL 113073 A IL113073 A IL 113073A IL 11307395 A IL11307395 A IL 11307395A IL 11307395 A IL11307395 A IL 11307395A IL 113073 A IL113073 A IL 113073A
Authority
IL
Israel
Prior art keywords
hydrogen
alkyl
oxo
group
amino
Prior art date
Application number
IL11307395A
Other languages
English (en)
Other versions
IL113073A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL113073A0 publication Critical patent/IL113073A0/xx
Publication of IL113073A publication Critical patent/IL113073A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11307395A 1994-03-24 1995-03-22 Pharmaceutical hypocholesterolemic and hypotriglyceridemic mercaptoacetylamide compositions containing disulfide derivatives of n-(tricyclic benzazepinyl) acetamide IL113073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21747194A 1994-03-24 1994-03-24

Publications (2)

Publication Number Publication Date
IL113073A0 IL113073A0 (en) 1995-06-29
IL113073A true IL113073A (en) 2001-03-19

Family

ID=22811224

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11307395A IL113073A (en) 1994-03-24 1995-03-22 Pharmaceutical hypocholesterolemic and hypotriglyceridemic mercaptoacetylamide compositions containing disulfide derivatives of n-(tricyclic benzazepinyl) acetamide

Country Status (18)

Country Link
US (1) US6013645A (de)
EP (1) EP0751774B1 (de)
JP (1) JPH10503468A (de)
CN (1) CN1144482A (de)
AT (1) ATE246927T1 (de)
AU (1) AU688012B2 (de)
CA (1) CA2184692C (de)
DE (1) DE69531489T2 (de)
DK (1) DK0751774T3 (de)
ES (1) ES2201100T3 (de)
FI (1) FI963784A7 (de)
HU (1) HUP9774624A2 (de)
IL (1) IL113073A (de)
NO (1) NO963988L (de)
NZ (1) NZ282565A (de)
PT (1) PT751774E (de)
WO (1) WO1995025519A1 (de)
ZA (1) ZA952289B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
GB0119305D0 (en) * 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (de) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
ZA833214B (en) * 1982-05-12 1983-12-28 Hoffmann La Roche Bicyclic compounds
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ES8801833A1 (es) * 1985-04-30 1988-02-16 Lilly Co Eli Un procedimiento para la preparacion de un compuesto.
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
ZA874107B (de) * 1986-06-13 1987-12-09
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
AU7168091A (en) * 1989-12-22 1991-07-24 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
DE69132379T2 (de) * 1990-06-06 2001-03-01 Ruth-Maria Korth Behandlung von Erkrankungen mit Paf-Antagonisten und Verfahren zur Bestimmung deren Wirksamkeit
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
DK0492369T3 (da) * 1990-12-21 1997-10-13 Merrell Pharma Inc Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
SG82630A1 (en) * 1992-04-20 2001-08-21 Takeda Chemical Industries Ltd 4,1-benzoxazepin derivatives and their use
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
EP0751774B1 (de) 2003-08-13
WO1995025519A1 (en) 1995-09-28
CA2184692C (en) 2001-01-02
US6013645A (en) 2000-01-11
ES2201100T3 (es) 2004-03-16
NO963988D0 (no) 1996-09-23
AU1972095A (en) 1995-10-09
CA2184692A1 (en) 1995-09-28
AU688012B2 (en) 1998-03-05
DE69531489T2 (de) 2004-04-08
NZ282565A (en) 1999-11-29
DE69531489D1 (de) 2003-09-18
JPH10503468A (ja) 1998-03-31
HU9602602D0 (en) 1996-11-28
ZA952289B (en) 1996-01-09
DK0751774T3 (da) 2003-12-08
PT751774E (pt) 2003-11-28
FI963784A0 (fi) 1996-09-23
NO963988L (no) 1996-11-22
FI963784L (fi) 1996-09-23
HUP9774624A2 (en) 1997-01-28
IL113073A0 (en) 1995-06-29
ATE246927T1 (de) 2003-08-15
FI963784A7 (fi) 1996-09-23
CN1144482A (zh) 1997-03-05
EP0751774A1 (de) 1997-01-08

Similar Documents

Publication Publication Date Title
AU669716B2 (en) 4-mercaptoacetylamino-(2) benzazepinone(3) derivatives, and use as enkephalinase inhibitors
CA2146238C (en) Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
AU2013302519A1 (en) Deuterated baricitinib
IL113073A (en) Pharmaceutical hypocholesterolemic and hypotriglyceridemic mercaptoacetylamide compositions containing disulfide derivatives of n-(tricyclic benzazepinyl) acetamide
US20020169154A1 (en) Novel methods and compositions involving trk tyrosine kinase inhibitors and antineoplastic agents
CA2183320C (en) Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
WO2010107791A2 (en) Pyrazinoisoquinoline compounds
WO2015031741A1 (en) Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
AU705029B2 (en) Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
US5624921A (en) Hypotriglyceridemic aminoacetylmercapto derivatives
US5567814A (en) 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
NZ278501A (en) Pyridobenzazepines and analogs with dipeptide structure; medicaments

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.